White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s disease

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2020
Source ID
10.1016/j.nicl.2020.102367

Entities

People

  • D. Louis Collins
  • Karen Misquitta
  • Mahsa Dadar
  • Maria Carmela Tartaglia

Organizations

  • AbbVie
  • Alzheimer's Disease Neuroimaging Initiative
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • Foundation for the National Institutes of Health
  • GE HealthCare
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Northern California Institute for Research and Education
  • Perrigo Company Plc
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • University of Southern California